Could Increased Glp1r Expression via Sitagliptin in the GLP-1/GLP-1 Receptor Axis in the DietInduced Obesity Rat Model be Important in Liver Metabolism?
Objective: The aim of this study was to evaluate the contribution of sitagliptin, which is used in the treatment of type 2 diabetes mellitus due to its insulinotropic effects, to the levels of glucagon-like peptide-1 (GLP-1) expressed in many systemic tissues in obesity, in liver, skeletal muscle, a...
Saved in:
| Main Authors: | Cem Horozoğlu, Serkan Gürgül, Gülper Nacarkahya, Neslihan Cevik |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Istanbul University Press
2024-12-01
|
| Series: | Experimed |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/en/download/article-file/4282885 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity
by: Vijay Kumar
Published: (2025-07-01) -
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01) -
GLP-1 and Its Role in Glycogen Production: A Narrative Review
by: Joseph Lotosky, et al.
Published: (2025-06-01) -
Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
by: Xu He, et al.
Published: (2025-01-01) -
GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
by: Wu Li, et al.
Published: (2024-12-01)